Background
In
Plasmodium falciparum malaria holoendemic transmission regions, such as western Kenya, malaria manifests with a milieu of life-threatening conditions including severe malarial anemia (SMA), metabolic acidosis, high-density parasitemia (≥10,000 parasites/μL), respiratory distress, hypoglycaemia and other infrequent complications such as hypotension [
1]. Even though not fully understood, severe clinical malaria is a multi-factorial process involving sequestration of infected red blood cells (iRBCs) in particular organs such as spleen [
2], bone marrow suppression leading to dyserythropoiesis [
3], and limited, malaria-specific antibody immunity and dysregulation in inflammatory responses [
4]. Due to the gradual development of immunity against
P. falciparum malaria in holoendemic areas, infants and young children suffer the greatest disease burden. The most common clinical manifestation of severe
P. falciparum malaria infection in pediatric populations of western Kenya is SMA (hemoglobin, Hb < 6.0 g/dL, any density parasitemia) [
5].
The binding of immunoglobulin domains to Fc receptors on target cells is important to initiate immunological defense against pathogens including antigen presentation, phagocytosis, cytotoxicity, induction of inflammatory processes and modulation of immune responses [
6]. Therefore, Fc gamma receptors (FcγRs) are important in providing a significant link between the humoral and cellular immunity by bridging the interaction between specific antibodies and effector cells [
7]. Previous studies demonstrate that polymorphic variability in these receptors is an important determinant of susceptibility to infections [
8,
9].
Previous investigations have also shown that the efficacy of the cellular immune response is influenced by FcγR polymorphisms, and consequently, influence clinical outcomes for infectious diseases’ such as malaria [
9,
10]. The human FcγRIIA mediates phagocytic function of monocytes, macrophages and neutrophils. The presence of FcγRIIA-131Arg/131His polymorphism affects the binding to the IgG
1 and IgG
3 [
11]. As reviewed Grant and colleagues [
12], FcγRIIA-131His/His homozygotes is associated with higher IgG
2 levels and protection against high parasitemia and has been considered as protective against blood stage
P. falciparum infection both in African and Asian populations [
13].
FcγRIIIA is an activating receptor with two co-dominantly expressed alleles, the 176 V and the 176F that differ in an amino acid at position 176 in the extracellular domain (valine or phenylalanine, respectively) [
14]. Dimorphisms in the amino acid at position 176F/V influences the binding of the immunoglobin G (IgG) subtype, with the 176 V variant having higher binding affinity for monomeric forms of IgG
1 and IgG
3, as compared to the 176F [
15] which is potentially important in infectious disease immunity.
On the surface of polymorphonuclear leucocytes, the most abundantly expressed FcγRs is the FcγRIIIB. These receptors exhibits two allotypic forms i.e. neutrophil antigens (NAs) 1 and 2 which differ in minor amino acids at position 65 and 82 in two extra-glycosylation site in NA2 [
16,
17] with different binding affinities. The NA2/NA2 allotype is associated with low immunoglobulin-mediated phagocytosis [
18,
19]. The phagocytosis of IgG
1-and IgG
3-opsonized immune complexes is more efficient on neutrophils bearing FcγRIIIB-NA1 relative to FcγRIIIB-NA2 [
18].
A number of genetic association studies have provided evidence that polymorphic variation in FcγRs have a strong effect on susceptibility to inflammatory mediated diseases [
20‐
24]. Even though FcγRs are important in the immune response to infection, the effect of its haplotypes on susceptibility to SMA in immune-naїve children remain largely undetermined. In the present study, we determined the association between FcγRIIA, IIIA and IIIB haplotypes and SMA, and the influence of these haplotypes on peripheral parasite burden during acute falciparum infections in an extensively phenotyped cohort of children from a
P. falciparum holoendemic transmission area western in Kenya.
Discussion
Based on the observations that Fc gamma receptors (FcγRs) are important contributory factors for infectious disease immuno-pathogenesis, the association between the FcγRIIA-131Arg/His, FcγRIIIA-176F/V and FcγRIIIB-NA1/NA2 polymorphisms and pediatric severe malaria anemia (SMA; Hb < 6.0 g/dL, any density parasitemia) was determined. We further assessed whether the carriage of different haplotypes of FcγRs were associated with parasite levels in P. falciparum infections. The current study demonstrated that the FcγRIIA-131Arg/ FcγRIIIA-176F/FcγRIIIBNA2 haplotype was associated with an increased susceptibility to SMA, while the FcγRIIA-131Arg/ FcγRIIIA-176F/ FcγRIIIBNA1 haplotype was associated with increased levels of circulating parasites during infection. However, there was no association between the individual genotypes and SMA in this pediatric population from western Kenya.
The FcγRs constitute a crucial arm of host immune defense against extracellular challenges by infectious agents through engagement of IgGs to enable innate immune effectors cells carry out phagocytosis and other downstream processes leading to immunity [
14,
31]. Some polymorphisms in the FcγRs have been identified as genetic determinants of susceptibility to infectious diseases [
21,
32]. The FcγRIIA-131Arg/His polymorphism leads to Histidine to Arginine change at 131 located at its second extracellular immunoglobulin-like domain [
8,
33]. The FcγRIIA-31His/His has efficient binding to IgG
2 as opposed to FcγRIIA-131Arg/Arg. In addition, the IgG
2 and IgG
3 antibodies have been shown to confer resistance to malaria by some studies [
34,
35]. In our current study, however, we did not find any association between FcγRIIA-131Arg/His polymorphism and SMA. An earlier study [
23] in Ghanaian children demonstrated that FcγRIIA-131His/His was associated with an increased risk of severe malaria anemia, but not cerebral malaria or any other malarial complication. Of note is the fact that a number of studies have shown contradictory results on the actual role of this variant on malarial disease severity [
36,
37]. These discrepancies may be attributed to clinical definitions of malaria, different genetic backgrounds from ethnic diversity and overall sample (population) size in previous studies.
The FcγRIIIA-176F/V gene displays a functional allelic polymorphism that generates allotypes exhibiting different receptor properties [
38]. Our study revealed no association between the FcγRIIIA-176F/V polymorphism and susceptibility to SMA in this pediatric population. This may imply that this particular variant is not independently associated with susceptibility to SMA which is consistent with our previous study involving the combined effect of toll-like receptor 9 and FcγRIIIA polymorphisms [
39]. The FcγRIIIB is a C-terminus linked glycosylphosphatidylinositol (GPI) moiety anchored receptor, exclusively expressed on neutrophils with three characterized allotypes i.e. human neutrophil antigen (HNA-1a or NA1, HNA-1b or NA2 and HNA-1c or SH) [
27]. The NA variants, NA1 and NA2, are a product of five non-synonymous SNPs in the first Ig-like domain, with an asparagine to serine switch at amino acid position 65 resulting in glycosylation and reduced affinity in the NA2 allele [
19,
38]. In the current study, we did not observe an association between either the NA1 or NA2 allotypes and susceptibility to SMA using common genetic models i.e., dominant, additive and recessive models. However, in Ghanaian children aged 1 to 12 years, the FcγRIIIB-NA2 was associated with susceptibility to clinical malaria [
40]. In a different study of malaria patients in Thailand, the FcγRIIIB-NA2 allotype was associated with cerebral malaria, but not other forms of severe malaria [
21]. Given the differences in findings from different populations and a diversity of clinical manifestations associated with malaria, the exact role of FcγRIIIB-NA2 in mediating outcome of malarial disease remains to be further explored.
It is important to note that FcγRs function synergistically, especially via crosslinking, resulting in phagocytosis of immunoglobulin-opsonized immune complexes or through stimulation of neutrophil granulation leading to production of reactive oxygen species (ROS) [
41,
42]. Moreover, the additive and interaction effects of host genotype and infection affect malaria outcome [
43] in malaria. In the current study, haplotypic analysis revealed that carriage of the FcγRIIA-131Arg/FcγRIIIA-176F/FcγRIIIBNA2 haplotype was associated with susceptibility to SMA. This is not surprising given that the haplotype had a higher frequency in the SMA group relative to the non-SMA group. Consistent with these observations, previous studies have demonstrated that the FcγR-131Arg/Arg is associated with low phagocytic activity and poor immune complex clearance [
33], which may imply that its inheritance as a haplotype, together with FcγRIIIA-176F and the FcγRIIIBNA2 allotypes, impart decreased cellular responses to IgG-mediated stimulation [
15,
18], and subsequently, susceptibility to SMA. Although the exact mechanisms through which the FcγRIIA-131Arg/FcγRIIIA-176F/FcγRIIIBNA2 haplotype result in severe malaria susceptibility were not evaluated in the current study, it is scientifically plausible to propose that carriage of the haplotype may lead to a reduced crosslinking in neutrophils, hence low phagocytic activity resulting in reduced antibody dependent respiratory burst (ADRB), a mechanism by which neutrophils provide protection against clinical malaria [
44‐
46]. Moreover, the FcγRIIA-131Arg/Arg, FcγRIIIA-176F/F and FcγRIIIB-NA2 allotypes are associated with low binding to cytophilic antibodies, which have been shown to play major roles in ADRB [
47,
48]. Taken together, the FcγRIIA-131Arg/FcγRIIIA-176F/FcγRIIIBNA2 haplotype may culminate in a reduced protective inflammatory response leading to enhanced susceptibility in children with SMA.
The finding that the FcγRIIA-131His/FcγRIIIA-176F/FcγRIIIBNA1 haplotype was associated with higher parasitemia levels is fascinating given the fact that the FcγRIIA-131His/His and FcγRIIIB-NA1 allotypes in this haplotype construct are associated with effective binding to cytophillic IgGs [
49], leading to clearance of opsonized parasites as opposed to the FcγRIIIA-176 F/F. One possible explanation for this observation could be that high levels of parasitemia in the haplotype may be associated with the diluting effect of the FcγRIIA-176F allele, which has a low binding to cytophylic antibodies [
15], and hence reduced clearance of parasites. However, it is worth noting that FcγRIIIA binding of IgG is important in induction of natural killer (NK) cells stimulatory properties which results in release of pro-inflammatory mediators, such as IL-1β, interferon-γ and tumor necrosis factor-α [
50] whose imbalances have been implicated in pathogenesis of clinical malaria in children.
Differences in the allelic frequencies of the FcγRs SNPs observed in the current study likely suggest their indirect influence on malaria susceptibility and pathogenesis in the current population. The deviation from HWE of FcγRIIIB NA1/NA2 genotypes in the current study remains consistent with the results of FcγRIIIB genetic polymorphisms performed in our previous reporting in which we included 528 children [
22]. It is likely that the observed NA1/NA2 genotype frequencies were in part due to consanguinity, however, this effect was not determined in the current study population. As much as HWE inconsistency may be due to genotyping errors [
51], it is worth noting that the likelihood of this error was significantly reduced since in our previous population [
22] we genotyped both FcγRIIA -131Arg/His and FcγRIIIB-NA1/NA2 using RFLP method in which the genotype frequencies were comparable to those in the current population in which TaqMan genotyping was used for FcγRIIA -131Arg/His. We thus hypothesize that the observed HWE deviation in FcγRIIIB could be due to unidentified mutation likely resulting from disease-related evolutionary selection pressure by
P. falciparum (and potentially by other infectious disease in the population) that does not affect the neighboring FcγRIIA and FcγRIIIA genes. This, however, remains to be determined most preferably by whole genome sequencing so as to develop a conclusive explanation.
In summary, the current study demonstrates that FcγRs haplotypes, but not individual genotypes are associated with malarial disease severity, demonstrating the combinatorial effects of FcγRs on influencing clinical malaria outcomes. Future studies aimed at longitudinally measuring immune complexes over time will help to delineate the important role of FcγR haplotypes on susceptibility to severe malaria in pediatric populations.
Acknowledgements
We are grateful to the Siaya County Referral Hospital for clinical support. We are indebted to the parents/guardians of the study participants and children who took part in the study. This work is published with the approval of the Director, KEMRI.